Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
DBV Technologies Spikes on Positive FDA Communication
By Tony Owusu
Jan 15, 2021 11:20 AM EST
INVESTING
DBV Technologies Spikes on Positive FDA Communication
By Tony Owusu
Jan 15, 2021 11:20 AM EST
PRESS RELEASES
DBV Technologies Provides Update On Investigational Viaskin™ Peanut For Children Ages 4-11 Years
By GlobeNewswire
Jan 14, 2021 4:30 PM EST
PRESS RELEASES
DBV Technologies Announces Change In U.S. Reporting Status And Final Approval Of Global Restructuring Process
By GlobeNewswire
Jan 7, 2021 1:30 AM EST
PRESS RELEASES
DBV Technologies Announces Leadership Changes
By GlobeNewswire
Nov 24, 2020 1:30 AM EST
PRESS RELEASES
DBV Technologies To Highlight Data On Viaskin™ Peanut Treatment Delivery And Patient Experience At ACAAI 2020
By GlobeNewswire
Nov 10, 2020 1:30 AM EST
PRESS RELEASES
DBV Technologies To Participate In Upcoming Investor Conferences
By GlobeNewswire
Nov 9, 2020 1:30 AM EST
INVESTING
Endurance International, Farfetch: 5 Top Stock Gainers for Monday
By Rob Lenihan
Nov 2, 2020 4:27 PM EST
STOCKS
DBV Soars on European Validation of Peanut Allergy Patch Application
By Rob Lenihan
Nov 2, 2020 11:50 AM EST
PRESS RELEASES
DBV Technologies Announces Filing And Validation Of Marketing Authorization Application For Viaskin™ Peanut By European Medicines Agency
By GlobeNewswire
Nov 2, 2020 1:30 AM EST
PRESS RELEASES
DBV Technologies Reports September 30, 2020 Cash Position
By GlobeNewswire
Oct 30, 2020 2:30 AM EDT
PRESS RELEASES
DBV Technologies Announces Leadership Changes
By GlobeNewswire
Sep 9, 2020 1:30 AM EDT
PRESS RELEASES
DBV Technologies To Participate In Multiple September Investor Conferences
By GlobeNewswire
Sep 2, 2020 4:30 PM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Investigation Of DBV Technologies Announced By Holzer & Holzer, LLC
By Business Wire
Aug 4, 2020 5:09 PM EDT
PRESS RELEASES
DBV Technologies Receives Complete Response Letter From FDA For Viaskin Peanut BLA In Children Ages 4-11 Years
By GlobeNewswire
Aug 4, 2020 1:30 AM EDT
PRESS RELEASES
DBV Technologies Reports First Half 2020 Financial Results
By GlobeNewswire
Jul 31, 2020 1:30 AM EDT
PRESS RELEASES
Half-Year Report On The DBV Technologies Liquidity Contract With ODDO BHF
By GlobeNewswire
Jul 20, 2020 4:01 PM EDT
PRESS RELEASES
DBV Technologies Announces Publication Of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut In The Journal Of Allergy And Clinical Immunology
By GlobeNewswire
Jul 10, 2020 9:00 AM EDT
PRESS RELEASES
DBV Technologies Provides Operational And Business Update
By GlobeNewswire
Jun 26, 2020 2:30 AM EDT
PRESS RELEASES
DBV Technologies To Present Data On Epicutaneous Immunotherapy And Food Allergy Quality Of Life At EAACI Digital Congress 2020
By GlobeNewswire
Jun 4, 2020 4:30 PM EDT
PRESS RELEASES
DBV Technologies To Present At The Goldman Sachs 41st Annual Global Healthcare Conference
By GlobeNewswire
Jun 2, 2020 4:30 PM EDT
PRESS RELEASES
DBV Technologies Reports March 31, 2020 Cash Position
By GlobeNewswire
Apr 30, 2020 4:01 PM EDT
PRESS RELEASES
DBV Technologies Announces Results Of Its 2020 Ordinary And Extraordinary General Meeting
By GlobeNewswire
Apr 20, 2020 4:01 PM EDT
PRESS RELEASES
Ordinary And Extraordinary General Meeting Of April 20, 2020 To Be Held In Closed Virtual Session Due To COVID-19 Pandemic
By GlobeNewswire
Apr 10, 2020 4:01 PM EDT
PRESS RELEASES
Ordinary And Extraordinary General Meeting Of April 20, 2020
By GlobeNewswire
Mar 30, 2020 4:01 PM EDT
